J Renal Inj Prev. 2012 Sep 01;1(2):55-9. doi: 10.12861/jrip.2012.20. eCollection 2012.
Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients.
Journal of renal injury prevention
Hamid Nasri
Affiliations
Affiliations
- Department of Nephrology, Shahrekord University of Medical Sciences, Shahrekord, Iran.
PMID: 25340109
PMCID: PMC4205986 DOI: 10.12861/jrip.2012.20
Abstract
INTRODUCTION: Numerous studies have attempted to identify risk factors for mortality and morbidity in maintenance hemodialysis patients. In this study we sought to examine the association of the levels of serum C-reactive protein (CRP) with value of Ca×PO4 product, in stable hemodialysis patients.
PATIENTS AND METHODS: Based on the severity of secondary hyperparathyroidism, patients being treated with oral active vitamin D3, calcium carbonate/Renagel tablets at various doses. Fasting serum 25-hydroxy vitamin D and intact serum parathormone and also serum blood urea nitrogen, CRP, calcium, phosphorus, alkaline phosphatase was measured.
RESULTS: A total of 41 patients, enrolled to the study. The mean patients' age were 46(17.6) years. The value of serum CRP of patients was 8.6 (6.6) mg/l (median 6 mg/l). The value of Ca×PO4 product was 50.5(15.5) mg2/dl2 (median: 50 mg(2)/dl(2)). In this study, a significant inverse association between Ca×PO4 product and the age of the patients was seen. A significant positive correlation of logarithm of serum CRP with Ca×PO4 product was found.
CONCLUSION: The result of this study, revealed the need to further attention to hyperphosphatemia in hemodialysis patients.
Keywords: End-stage renal disease; Hemodialysis; Hyperphosphatemia
References
- Nephrol Dial Transplant. 2001 Apr;16(4):809-15 - PubMed
- J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S28-36 - PubMed
- Circ Res. 2000 Sep 29;87(7):E10-7 - PubMed
- Kidney Int. 1999 Feb;55(2):648-58 - PubMed
- Nephron Clin Pract. 2005;101(4):c161-7 - PubMed
- Kidney Int. 1999 May;55(5):1899-911 - PubMed
- Kidney Int. 2003 Mar;63(3):1003-11 - PubMed
- J Am Soc Nephrol. 1996 Oct;7(10):2169-75 - PubMed
- Blood Purif. 1999;17(2-3):142-8 - PubMed
- Am J Kidney Dis. 2001 Dec;38(6):1408-13 - PubMed
- Kidney Int. 2002 Dec;62(6):2238-45 - PubMed
- J Am Soc Nephrol. 2001 Oct;12(10):2131-8 - PubMed
- JAMA. 1987 Feb 6;257(5):645-50 - PubMed
- Hypertension. 2001 Oct;38(4):938-42 - PubMed
- Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2348-54 - PubMed
- Circulation. 2001 Jan 2;103(1):5-6 - PubMed
- Nephrol Dial Transplant. 2003 Sep;18(9):1731-40 - PubMed
- N Engl J Med. 1999 Jan 14;340(2):115-26 - PubMed
- Am J Kidney Dis. 1998 Apr;31(4):607-17 - PubMed
- Curr Opin Struct Biol. 1999 Aug;9(4):433-7 - PubMed
- Eur J Clin Invest. 2001 Jun;31(6):467-8 - PubMed
- Am J Kidney Dis. 1996 Dec;28(6):910-7 - PubMed
- Nephrol Dial Transplant. 1999 Aug;14(8):1956-60 - PubMed
- Am J Kidney Dis. 1990 May;15(5):458-82 - PubMed
- Kidney Int Suppl. 2003 Jun;(85):S111-4 - PubMed
- N Engl J Med. 1997 Apr 3;336(14):973-9 - PubMed
- J Am Soc Nephrol. 2004 Aug;15(8):2208-18 - PubMed
- Am J Kidney Dis. 2000 Mar;35(3):469-76 - PubMed
Publication Types